期刊文献+

EFFECT OF BcL-2 ANTISENSE DRUG WITH DIFFERENT STRUCTURE ON THE BIOLOGICAL FUNCTION OF K562 CELLS

EFFECT OF BcL-2 ANTISENSE DRUG WITH DIFFERENT STRUCTURE ON THE BIOLOGICAL FUNCTION OF K562 CELLS
在线阅读 下载PDF
导出
摘要 Objective: To study the differences and similarities of the antisense drugs with different structures on the biological functions of K562 cells. Methods: Cytotoxic effects were measured by use of a cell viability assay. Flow cytometric analysis and agarose gel electrophoresis of DNA fragmentation were also performed. The expression level of protein was assayed by immunofluorescence using fluoresce isothiocyanate label. Results: PNA targeting the coding region of the Bcl-2 messenger RNA could effectively inhibit K562 cell viability, down-regulate the synthesis of the Bcl-2 protein and increase cell apoptosis. By 72 h after the Bcl-2 antisense PNA treatment, K562 cells showed more reduction in the level of Bcl-2 protein compared with cells treated with the antisense ODN. After treatment with 10 μmol/L of Bcl-2 antisense PNA or antisense ODN for 72 h, apoptotic rates of K562 cells were 13.15±1.13 and 11.72±1.12, respectively. Furthermore, there was significant difference in the percentage of apoptotic cells between antisense PNA group and antisense ODN group. Conclusion: The results suggest that antisense PNA targeting the coding region of Bcl-2 mRNA has better antisense effects than the antisense oligonucleotides on inducing apoptosis of K562 cells. Key words Bcl-2 - Antisense peptide nucleic acid - Antisense oligonucleotide - K562 cells - Apoptosis CLC number Q255 Foundation item: This work was supported by the Key Foundation of Science & Technology Program of Guangzhou (No.2001-Z-037-01), and the Nature Science Key Foundation of Guangdong Province (No. 021195).Biography: LEI Xiao-yong(1970–), male, associate professor, doctor of medicine, Institute of Pharmacy and Pharmacology, Nanhua University, majors in tumor pharmacology. Objective: To study the differences and similarities of the antisense drugs with different structures on the biological functions of K562 cells. Methods: Cytotoxic effects were measured by use of a cell viability assay. Flow cytometric analysis and agarose gel electrophoresis of DNA fragmentation were also performed. The expression level of protein was assayed by immunofluorescence using fluoresce isothiocyanate label. Results: PNA targeting the coding region of the Bcl-2 messenger RNA could effectively inhibit K562 cell viability, down-regulate the synthesis of the Bcl-2 protein and increase cell apoptosis. By 72 h after the Bcl-2 antisense PNA treatment, K562 cells showed more reduction in the level of Bcl-2 protein compared with cells treated with the antisense ODN. After treatment with 10 μmol/L of Bcl-2 antisense PNA or antisense ODN for 72 h, apoptotic rates of K562 cells were 13.15±1.13 and 11.72±1.12, respectively. Furthermore, there was significant difference in the percentage of apoptotic cells between antisense PNA group and antisense ODN group. Conclusion: The results suggest that antisense PNA targeting the coding region of Bcl-2 mRNA has better antisense effects than the antisense oligonucleotides on inducing apoptosis of K562 cells. Key words Bcl-2 - Antisense peptide nucleic acid - Antisense oligonucleotide - K562 cells - Apoptosis CLC number Q255 Foundation item: This work was supported by the Key Foundation of Science & Technology Program of Guangzhou (No.2001-Z-037-01), and the Nature Science Key Foundation of Guangdong Province (No. 021195).Biography: LEI Xiao-yong(1970–), male, associate professor, doctor of medicine, Institute of Pharmacy and Pharmacology, Nanhua University, majors in tumor pharmacology.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2004年第2期109-112,共4页 中国癌症研究(英文版)
基金 This work was supported by the KeyFoundation of Science & Technology Program of Guangzhou(No.2001-Z-037-01) and the Nature Science Key Foundationof Guangdong Province (No. 021195).
关键词 BCL-2 Antisense peptide nucleic acid Antisense oligonucleotide K562 cells APOPTOSIS Bcl-2 Antisense peptide nucleic acid Antisense oligonucleotide K562 cells Apoptosis
  • 相关文献

二级参考文献16

  • 1Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance [J]. Curr Opin Oncol,1995,7:541-546.
  • 2Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line [J].Blood,1993, 81: 151-157.
  • 3Fisher TC, Milner AE, Gregory CD, et al. Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways [J]. Cancer Res, 1993,53:3321-3326.
  • 4Bilim V,Kasahara T,Noboru H,et al.Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and adriamycin on transitional cell cancer cells [J].Cancer Lett,2000,155:191-198.
  • 5Bloem A, Lockhorst H. Bcl-2 antisense therapy in multiple myeloma [J]. Pathol Biol, 1999, 47:216-220.
  • 6Campos L, Sabido O, Rouault JP, et al. Effects of bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells [J]. Blood, 1994, 84:595-600.
  • 7Keith FJ, Bradbury DA,Zhu YM, et al. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C [J]. Leukemia,1995, 9:131-138.
  • 8John C, Reed. Bcl-2 prevention ofapoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am, 1995;9(2):451
  • 9Kobzdej M, Matuszyk J, Ziolo E, et al. Changes in glucocorticoid-induced apoptosisand in expression of Bcl-2 protein during long-term culture of thymic lym phoma. ArchImmunol Ther Exp, 2000; 48(1): 43
  • 10Bilim V, Kasahara T, Noboru H, et al. Caspase involved synergistic cytotoxicity ofbcl-2 antisense oligonucleotides and adriamycin on transitional cell cancercells. CancerLett (IRELAND), 2000; 155(2): 191

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部